MannKind Corp (MNKD) Stock Analysis
Verdict: HOLD
Niche insulin dominance and royalty flows struggle against a debt-heavy balance sheet and extreme earnings volatility.
Investment score: 62/100
Analysis as of
Is MannKind Corp stock worth reviewing? The TradeMates thesis
MannKind is in a precarious transition from a 'burn' story to a cash-flow-positive entity. While operational margins are improving (11.36%), the balance sheet remains underwater with $473M in debt and negative equity. The CEO's recent purchase provides a tactical sentiment floor, but the technical trend remains bearish.
7-factor investment score
- Valuation: 55/100 (weight 20%)
- Financial Health: 70/100 (weight 15%)
- Technical Momentum: 45/100 (weight 15%)
- Earnings Quality: 40/100 (weight 15%)
- Insider Sentiment: 85/100 (weight 10%)
- Analyst Consensus: 90/100 (weight 10%)
- Risk-Adjusted Return: 50/100 (weight 15%)
MannKind Corp opportunities and risks
What speaks for MNKD
- Insider Support at Key Levels
What speaks against MNKD
- High Earnings Volatility and Misses
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| MNKD | 149.1x | 2.5x | 24.6x | 76.4% | 1.7% | 1.5% |
| CGEM | n/a | 0.0x | n/a | 0.0% | 0.0% | -15.1% |
| XNCR | n/a | 7.5x | n/a | 93.7% | -73.2% | -14.7% |
| MGTX | n/a | 11.1x | n/a | 94.0% | -140.3% | -6.3% |
| SPRY | n/a | 10.6x | n/a | 75.8% | -203.3% | -19.1% |
| CTMX | n/a | 9.1x | n/a | 99.3% | -22.8% | -10.9% |
| Peer median | n/a | 9.1x | n/a | 93.7% | -73.2% | -14.7% |
Frequently asked questions about MannKind Corp (MNKD)
Is MNKD stock a good investment?
The TradeMates model rates MannKind Corp as HOLD with an investment score of 62/100. MannKind is in a precarious transition from a 'burn' story to a cash-flow-positive entity. While operational margins are improving (11.36%), the balance sheet remains underwater with $473M in debt and negative equity. The CEO's recent purchase provides a tactical sentiment floor, but the technical trend remains bearish. This is algorithmic model output, not personal investment advice.
Is MNKD stock a buy?
The TradeMates model verdict for MNKD is HOLD with an investment score of 62/100. Treat this as a model signal to review, not a personal buy recommendation.